Bharat Parenterals

Bharat Parenterals' wholly owned subsidiary, Varenyam Biolifesciences, approved a revised Phase 1 investment of ₹300 crore for its upcoming Savli facility, double the earlier plan of ₹150 crore. The project expanded from a regulated Rest-of-World oncology facility into two blocks serving biologics and biosimilar CDMO work alongside small-molecule oncology products, targeting the United States, European Union and SRA markets. Construction was targeted for completion by Q2 2028, with USFDA, EU-GMP and ANVISA approvals to be pursued. Varenyam Bio remained pre-revenue with ₹33.2 crore of CWIP in Q1 FY27, while Bharat Parenterals reported group revenue of ₹345.4 crore in FY26.

Powered by Tijori

April 21 (Reuters) - Bharat Parenterals Ltd BATP.BO:

• BHARAT PARENTERALS LTD - U.S. FDA CONDUCTS SURPRISE INSPECTION AT INNOXEL LIFESCIENCES VADODARA FACILITY

• BHARAT PARENTERALS LTD - U.S. FDA ISSUES FIVE OBSERVATIONS UNDER VAI CLASSIFICATION

Source text: ID:nBSEMcQmp

Further company coverage: BATP.BO

(([email protected];))

** Shares of Bharat Parenterals BATP.BO rise exchange-allowed maximum of 5% to 1,037.25 rupees

** Pharmaceutical co on Saturday said its unit Innoxel Lifesciences has cleared U.S. FDA inspection at its Vadodara facility

** Inspection concluded with issuance of a single observation under Form 483 which is procedural in nature - BATP

** A Form 483 is a type of agency report containing observations that FDA inspectors deem to be objectionable

** Stock down 29.3% YTD

(Reporting by Ashish Chandra in Bengaluru)

(([email protected] (+91 7982114624))

Jan 28 (Reuters) - Bharat Parenterals Ltd BATP.BO:

• SECURES $27 MILLION ORDER FOR PHARMACEUTICAL PRODUCTS

Source text: ID:nBSE7k7CV

Further company coverage: BATP.BO

(([email protected];;))

** Shares of Syschem (India) SYCH.BO rise as much as 15.6% to 55 rupees, hitting their highest since May 2024

** Active pharmaceutical ingredient maker to consider raising funds via issue of equity or warrants on Dec. 24

** SYCH eyes best day since Jan. 2024; on track to snap two-day losing run

** Stock up ~8% so far this year, on track for fifth straight year of gains

** Peer Bharat Parenterals BATP.BO surged ~102% YTD

(Reporting by Dimpal Gulwani in Bengaluru)

(([email protected]))

Nov 21 (Reuters) - Bharat Parenterals Ltd BATP.BO:

• UNIT OUT-LICENSES TWO MOLECULES TO GENERIC PHARMA MNCS

Source text: ID:nBSEbFrQh2

Further company coverage: BATP.BO

(([email protected];;))

June 24 (Reuters) - Bharat Parenterals Ltd BATP.BO:

• ACQUISITION OF ADDITIONAL STAKE IN INNOXEL LIFESCIENCES

• ACQUISITION OF VARENYAM HEALTHCARE

• ACQUISITION OF VARENYAM BIO-LIFESCIENCES

Source text for Eikon: ID:nBSE5Wt3cz

Further company coverage: BATP.BO

(([email protected];;))

June 10 (Reuters) - Bharat Parenterals Ltd BATP.BO:

• APPROVED RAISING OF FURTHER CAPITAL BY WAY OF ISSUE OF SHARES AT 1,465 RPEES PER SHARE

• APPROVED RAISING FURTHER CAPITAL VIA PREFERENTIAL ISSUE OF EQUITY SHARES

Further company coverage: BATP.BO

(([email protected];))

June 6 (Reuters) - Bharat Parenterals Ltd BATP.BO:

• BHARAT PARENTERALS - TO CONSIDER AND EVALUATE PROPOSAL FOR ISSUE OF EQUITY SHARES ON PREFERENTIAL BASIS

Source text for Eikon: ID:nBSE1bFthn

Further company coverage: BATP.BO

(([email protected];))

June 5 (Reuters) - Bharat Parenterals Ltd BATP.BO:

• BHARAT PARENTERALS LTD - CO WILL ACQUIRE ADDITIONAL 10 MILLION SHARES OF UNIT INNOXEL LIFESCIENCES

Source text for Eikon: ID:nBSE5yKtjz

Further company coverage: BATP.BO

(([email protected];))

April 29 (Reuters) - Bharat Parenterals Ltd BATP.BO:

• APPROVED RAISING OF FURTHER CAPITAL AGGREGATING TO 981.5 MILLION RUPEES

• APPROVED RAISING OF FURTHER CAPITAL BY WAY OF ISSUE OF SHARES ON A PREFERENTIAL BASIS

Source text for Eikon: ID:nBSE87MKXz

Further company coverage: BATP.BO

(([email protected];;))